Background: Leptin contributes to the pathogenesis of atherosclerosis, endothelial dysfunction, and thrombosis. Peripheral arterial disease (PAD) is a common manifestation of atherosclerosis and is expected to prevail among geriatric individuals. The present study aimed to determine whether serum leptin level is associated with PAD in a geriatric group. Methods: Blood samples were obtained from 60 participants in the study who were >65 years of age. Ankle-brachial index (ABI) values were measured using the automated oscillometric method. PAD was considered to be present if the left or right ABI values were less than 0.90, and these participants were included in the low ABI group. Serum leptin levels were measured using a commercial enzyme immunoassay kit. Results: Of these geriatric participants, ten (16.7%) were in the low ABI group. Compared with the elderly participants in the normal ABI group, those in the low ABI group were current smokers (p ¼ 0.048) and had higher serum C-reactive protein (CRP, p ¼ 0.018) and leptin levels (p ¼ 0.005). Multivariate logistic regression analysis of the factors significantly associated with PAD demonstrated that leptin (odds ratio: 1.078, 95% confidence interval: 1.021e1.138, p ¼ 0.006) was an independent predictor of PAD. Female (p ¼ 0.001), body mass index (p ¼ 0.008), and a logarithmically transformed CRP (log-CRP, p ¼ 0.035) were found to be associated with serum log-leptin levels among geriatric participants after multivariate forward stepwise linear regression analysis. Conclusion: High serum leptin level is a risk marker for PAD in geriatric individuals.
Introduction
Peripheral artery disease (PAD), which frequently occurs in the elderly, is a condition in which arteries connecting to the extremities become narrow or occult owing to an accumulation of fatty tissue. 1 One of the known risk factors of PAD is aging. 2 Within a population above 60 years of age, the overall incidence of PAD is approximately 20%. 3 PAD also results in elevated risk of other cardiovascular diseases, such as heart attack and ischemic stroke, even in asymptomatic individuals. 4 Ankle-brachial index (ABI) is an important tool for noninvasive detection of this disease. 5 An abnormal ABI, lower than 0.9, is an indicator of PAD and can be used to assess the severity of PAD. 6 There is evidence that an increase in plasma leptin level is associated with unfavorable outcomes in coronary artery disease and heart failure. 7, 8 Leptin induced detrimental responses including vascular inflammation, vasodilatation dysfunction, and arterial stiffness in peripheral tissues have been reported in previous studies. 9, 10 However, the relationship between PAD and high serum leptin level in geriatric individuals is unclear. Therefore, in the present study, we aimed to determine the relationship between serum leptin level and PAD in geriatric individuals.
Methods

Participants
In total, 60 participants aged >65 years were enrolled in this cross-sectional study conducted between January and December 2012 in a medical center in Hualien, Taiwan. Blood pressure (BP) of each patient was measured in the morning by trained staff using standard mercury sphygmomanometers with appropriate cuff sizes after the patient was seated for at least 10 min. Systolic and diastolic BP measurements were recorded thrice at 5-min intervals and were averaged for analysis. The patients were regarded as having hypertension if they had systolic BP ! 140 mmHg, diastolic BP ! 90 mmHg, or received any anti-hypertensive medication in the past 2 weeks. The patients were diagnosed with diabetes mellitus if their fasting plasma glucose level was !126 mg/dl or if they were administered oral hypoglycemic medication or insulin.
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The Protection of the Human Subjects Institutional Review Board of the Tzu-Chi University and Hospital approved this study. All of the patients provided informed consent prior to participating in this study. Patients were excluded if they had acute infection, acute myocardial infarction, or pulmonary edema, took proteaseactivated receptor-1 antagonists or Warfarin at the time of blood sampling, or declined to provide informed consent.
Anthropometric analysis
Participant weight was measured without shoes, while wearing light clothing to the nearest 0.5 kg, while height was measured to the nearest 0.5 cm. Body mass index (BMI) was calculated as the weight in kilograms divided by the height in meters squared. 
Biochemical investigation
After 8 h overnight fasting, blood (approximately 5 ml) of all participants was sampled at morning and were immediately centrifuged at 3000 Â g for 10 min. Serum levels of blood urea nitrogen), creatinine, fasting glucose, total cholesterol (TCH), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), lowdensity lipoprotein cholesterol (LDL-C), total calcium, phosphorus, and C-reactive protein (CRP) were measured using an autoanalyzer (COBAS Integra 800; Roche Diagnostics, Basel, Switzerland).
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Serum leptin (SPI-BIO, Montigny le Bretonneux, France) level and intact parathyroid hormone level (iPTH; Diagnostic Systems Laboratories, Webster, TX, USA) were determined using a commercially available enzyme immunoassay or enzyme-linked immunosorbent assay, respectively. 12,13
Ankle-brachial index measurements
Using an oscillometric method, ABI values were measured using an ABI-form device (VaSera VS-1000; Fukuda Denshi Co, Ltd, Tokyo, Japan) that automatically and simultaneously measures BP in both of the arms and ankles.
14 With the participants lying in the supine position, occlusion and monitoring cuffs were placed tightly around the four extremities, an electrocardiogram was recorded, and heart sounds were measured for at least 10 min. ABI was calculated as the ratio of ankle SBP to arm SBP, and the lower value of ankle SBP was used for calculation. We repeatedly measured these parameters for both legs and calculated the mean values. PAD was diagnosed on the basis of ABI <0.9. 15 In the present study, the left or right ABI values < 0.9 were used to define the low ABI group. 14 
Statistical analysis
Data were tested for normal distribution using the KolmogoroveSmirnov test. Normally distributed data were expressed as a mean ± standard deviation, and comparisons between the patients were performed using the Student's independent t-test (two-tailed). Non-normally distributed data were expressed as medians and interquartile ranges, and comparisons between the patients were performed using the ManneWhitney U test (TG, fasting glucose, CRP, and leptin). Data expressed as the number of patients were analyzed by the chi-square test. Because TG, fasting glucose, CRP, and leptin not normally distributed and underwent base 10 logarithmic transformations to achieve normality. Clinical variables that correlated with serum logarithmically transformed leptin (log-leptin) levels in the elderly participants were evaluated using univariate linear regression analysis. Variables that were significantly associated with log-leptin levels in the elderly participants were tested for independency in the multivariate forward stepwise regression analysis. Receiver operating characteristic (ROC) was used to calculate the area under the curve (AUC) to identify log-leptin and log-CRP levels to predict PAD in the participants. Variables that were significantly associated with PAD were tested for independence using multivariate logistic regression analysis. Data were analyzed using SPSS for Windows (version 19.0; SPSS Inc., Chicago, IL, USA). A p value < 0.05 was considered statistically significant.
Results
Demographic, clinical, and biochemical characteristics of the 60 geriatric participants are presented in Table 1 . Twenty-four of the participants (40.0%) had diabetes mellitus, and 47 (78.3%) had hypertension. Ten geriatric participants (16.7%) were included in the low ABI group. Those in the low ABI group had high frequency of current smoking (p ¼ 0.048) and higher serum CRP (p ¼ 0.018) and leptin (p ¼ 0.005) levels than those in the normal ABI group. There was no statistically significant difference based on gender, coexisting diabetes or hypertension, or the use of ACEi, ARB, bblockers, CCB, statins, fibrate, Aspirin, or Clopidogrel between the two groups.
The univariable and multivariate linear analysis of the log-leptin levels in the elderly participants are presented in Table 2 . The elderly females (r ¼ 0.
, and log-CRP (r ¼ 0.313, p ¼ 0.015) positively correlated with, while height (r ¼ À0.263, p ¼ 0.042) negatively correlated with the serum logleptin levels in the elderly participants. After a multivariate forward stepwise linear regression analysis of the factors (gender, height, BMI, DBP, TCH, and log-CRP) that were significantly associated with fasting serum log-leptin levels, it was demonstrated that the females (b ¼ 0.384, p ¼ 0.001), BMI (b ¼ 0.302, p ¼ 0.008) and log-CRP (b ¼ 0.241, p ¼ 0.035) were positively associated with serum log-leptin levels among the elderly participants.
Then a ROC curve analysis was applied to estimate the optimal level of log-leptin and log-CRP predicting the PAD of the elderly participants (Fig. 1) . The AUC for log-leptin was 0.782 (95% confidence interval (CI): 0.657e0.878, p ¼ 0.001), and AUC for log-CRP was 0.739 (95% CI: 0.609e0.844, p ¼ 0.004), respectively.
An adjustment of the factors significantly associated with PAD (diabetes mellitus, hypertension, smoking, gender, age, TCH, TG, HDL-C, LDL-C, CRP and leptin) in a multivariate logistic regression analysis demonstrated that each increase of 1 ng/ml in the serum leptin level (odds ratio: 1.0782, 95% CI: 1.021e1.138, p ¼ 0.006) and current smoking (odds ratio: 22.460, 95% CI: 1.428e353.336, p ¼ 0.027) were the independent predictors of PAD in the elderly participants (Table 3 ).
Discussion
The results of this study showed that the fasting leptin level was higher in the elderly adults in the low ABI group than in those in the normal ABI group, together with current smoking as independent predictors for the development of PAD.
A total of 6979 patients aged 70 years or older or aged 50 through 69 years with a history of cigarette smoking or diabetes throughout the United States demonstrated a 13% prevalence rate of PAD. 16 Another study also demonstrated a significantly increased prevalence of 23.5% in patients with PAD that were compared between 2000 and 2010, and a prevalence that increased more dramatically in the elderly was also reported. 17 Our study showed a PAD prevalence rate of 16.7% in an elderly population and also that current smoking is associated with PAD in elderly adults. Diabetes mellitus and hypertension were perceived as the risk factors of PAD. 18, 19 Our study demonstrated a prevalence of 50% of PAD in elderly adults with diabetes mellitus in this population similar to a previous epidemiologic study. 18 There was an 80% hypertension prevalence in the PAD elderly adults in our study. However, the prevalence of diabetes mellitus or hypertension did not manifest a statistical significance when comparing between the low ABI group and the normal ABI group in our study. Since PAD is recognized as an inflammation in peripheral tissue. 20 In a crosssectional study surveyed among 5874 adults without any other underlying disease, it was demonstrated that an elevated CRP was associated with PAD. 21 Moreover, CRP was also reported to be a predictor of PAD mortality. 22 Our study showed a positive correlation between CRP and PAD. Leptin stimulates vascular inflammation, causes oxidative stress, and vascular smooth muscle hypertrophy that may contribute to a pathogenesis of type 2 diabetes mellitus, hypertension, atherosclerosis, and coronary heart disease. 23 Hyperleptinemia was reported to be positively correlated to total peripheral resistance and inversely related to arterial compliance. 9 Elevated plasma leptin is known to be a key factor in arterial stiffness. 24 Leptin also induces the excretion of vasoconstrictor in endothelial cells, such as endothelin-1, which could also contribute to PAD. 25 In our study, hyperleptinemia was strongly related to PAD in an elderly population. After a multivariate logistic regression analysis, it was noted that the serum leptin level also predicts the diagnosis of PAD in elderly adults. Testosterone and a lean body mass increase in males while they age. As a result, body fat mass as well as leptin decreases after puberty in males. On the other hand, a fat body mass and leptin elevate in females while they age. 26 A previous study demonstrated an abrupt elevation of serum leptin when BMI exceeded the level of 24.6 kg/m 2 and also demonstrated that when BMI increased to 30 kg/m 2 , a decrease in the leptin receptor occurred. 27 A former study showed that a primary hepatocyte was stimulated by leptin and eventually increased the CRP secretion. 28 In addition, Calabr o et al. found that an elevation of leptin was also associated with an increase of the CRP level in human artery coronary endothelial Values for continuous variables are shown as mean ± standard deviation after analysis using the Student's t-test; variables not normally distributed are shown as the median and interquartile ranges after analysis using the ManneWhitney U test; values are presented as number (%) and analysis after analysis using the chi-square test. ABI, ankle brachial index; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; CRP, C-reactive protein; ACE, angiotensin-converting enzyme; ARB, angiotensin-receptor blocker; CCB, calcium-channel blocker. * p < 0.05 was considered statistically significant.
cells. 29 In this study, we found that leptin levels had a positive significant association with the female gender and with the BMI and CRP levels. Several limitations are emphasized in this study. First of all, this was a single-center investigation with a small number of participants. Another limitation is that pharmacological interventions have been shown to influence PAD in humans. Statin used in patients with PAD results in a decreased progression and even a regression in the growth of the atherosclerotic plaque. 30 There was no statistically significant difference based on statins used between elderly population with or without PAD in this study. Moreover, leptin is implicated in the association between sleep and lower leptin level is associated with sleep short sleep duration. 31 Circulating leptin concentration was proportional to body mass with body fat percentage and body fat was decreased in the elderly. 32 Although, blood sampling of this study is in the morning with overnight fasting about 8 h, but did not check body fat mass in elderly adults. Further studies are required before a cause-effect relationship between serum leptin and PAD can be established in elderly adults.
In conclusion, our study showed a significant difference in current smoking, and CRP and leptin levels by comparing a normal ABI group to a low ABI group in the elderly population. A higher serum leptin level and current smoking is associated with PAD in elderly adults. The female gender and the BMI and CRP levels were positively associated with the serum leptin levels in our study.
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